FDA says Day Light Nutrition markets four supplement products as unapproved drugs with disease-treatment claims on its website.
What happened
FDA reviewed www.daylightnutrition.com in July 2023 and found the company takes orders there for Above the Weather, Diabetic Support Blend, Joint Well, and ViruZap. FDA cited website and label claims that the products treat or prevent diseases such as flu, cold symptoms, diabetes/glucose problems, arthritis pain and inflammation, and viral or bacterial infections. FDA determined the products are unapproved new drugs and that three of them are misbranded because their directions are not adequate for safe lay use.
What FDA found
FDA says the products are drugs because the website claims they cure, mitigate, treat, or prevent disease.
section 201(g)(1)(B) of the Act [21 U.S.C. ยง 321(g)(1)(B)]FDA says the products are "new drugs" that lack FDA approval and were offered for interstate commerce.
section 201(p) of the Act [21 U.S.C. 321(p)]; sections 301(d) and 505(a) [21 U.S.C. 331(d), 355(a)]FDA says Above the Weather, Diabetic Support Blend, and ViruZap are misbranded because they lack adequate directions for safe use by a layperson.
section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]; 21 CFR 201.5FDA says offering these misbranded drugs for interstate commerce violates the Act.
section 301(a) of the Act [21 U.S.C. 331(a)]
What FDA wants
Within 15 working days of receipt, notify FDA in writing of the specific steps taken to address the violations and prevent recurrence, with related documentation. If corrections cannot be completed in that time, state the reason for the delay and when they will be done; if the company believes it is not in violation, include its reasoning and supporting information.
Who should pay attention
- retailers and online marketplaces selling supplement products
- brands making disease-related claims for supplements
- consumers using supplements for flu, diabetes, joint pain, or infections
This is a summary. Read the original letter on fda.gov.